ArticlemBio2020
A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates.
Erratum issuedOpen access · goldAbstract read
In one paragraph
Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 25 citations in OpenAlex.
- Comparison ofInfection and immunity · 2026Article
- Genomic analysis reveals multi-lineage carbapenem-resistant Pseudomonas aeruginosa mimicking a hospital outbreak.BMC microbiology · 2026Article
- Comparison ofbioRxiv : the preprint server for biology · 2026Article
- Pathogenicity and virulence ofVirulence · 2025Review
- Whole-genome phenotype prediction with machine learning: open problems in bacterial genomics.Bioinformatics (Oxford, England) · 2025Article
- Molecular characterization of virulent genes in Pseudomonas aeruginosa based on componential usage divergence.Scientific reports · 2025Article
- tesG expression as a potential clinical biomarker for chronic Pseudomonas aeruginosa pulmonary biofilm infections.BMC medicine · 2025Article
- Refined methodology for quantifyingMicrobiology spectrum · 2025Article
- In-depth genome and comparative genome analysis of a metal-resistant environmental isolateFrontiers in cellular and infection microbiology · 2025Article
- Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection.Communications medicine · 2024Article
- Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective.Infection · 2024Review
- Phylogenetic evaluation and genotypic identification of burn-related Pseudomonas aeruginosa strains isolated from post-burn human infections during hospitalization.Pathogens and disease · 2024Article
- Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital.Microbiology spectrum · 2023Article
- Single nucleotide variants inMicrobial genomics · 2023Article
- Evolution-proof inhibitors of public good cooperation: a screening strategy inspired by social evolution theory.FEMS microbiology reviews · 2022Article
- Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections.Nature communications · 2022Article
- Pseudomonas aeruginosa clinical blood isolates display significant phenotypic variability.PloS one · 2022Article
- A genomic data resource for predicting antimicrobial resistance from laboratory-derived antimicrobial susceptibility phenotypes.Briefings in bioinformatics · 2021Article
- Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniae.mSystems · 2021Article
- Forest and Trees: Exploring Bacterial Virulence with Genome-wide Association Studies and Machine Learning.Trends in microbiology · 2021Review
Corrections and comments
- Erratum issued
Authors and funding
11 authors at 5 institutions in 3 countries.
Nathan B PincusDepartment of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-3134-7176
Egon A OzerDepartment of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-7131-3691
Jonathan P AllenDepartment of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Marcus NguyenUniversity of Chicago Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois, USA.
James J DavisUniversity of Chicago Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois, USA.
Deborah R WinterDepartment of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Chih-Hsien ChuangSchool of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan.
Cheng-Hsun ChiuMolecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.ORCID 0000-0003-4324-7743
Laura ZamoranoServicio de Microbiología y Unidad de Investigación, Hospital Universitari Son Espases, Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.
Antonio OliverServicio de Microbiología y Unidad de Investigación, Hospital Universitari Son Espases, Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.ORCID 0000-0001-9327-1894
Alan R HauserDepartment of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA ahauser@northwestern.edu.ORCID 0000-0003-4596-7939
Northwestern University · USArgonne National Laboratory · USHealth Research Institute of the Balearic Islands · ESChang Gung University · TWFu Jen Catholic University · TW
Funding
BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES75N93019C00076 · NIAID · UNIVERSITY OF CHICAGO · PI STEVENS, RICK · 2019 to 2023
$32.6MTechnology CoreU19AI135964 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RICHARD G WUNDERINK · 2018 to 2026
$24.7MMEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0MCELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1MMedical Scientist Training ProgramT32GM144295 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ALAN R HAUSER · 2022 to 2026
$9.1MPopulation Analysis of Pseudomonas aeruginosa VirulenceR01AI118257 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2016 to 2025
$4.9MPatient-Oriented Research on Pseudomonas aeruginosaK24AI104831 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2013 to 2024
$1.2MBiomarkers for Highly Virulent Pseudomonas aeruginosa StrainsR21AI129167 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2017 to 2018
$570kNIAID NIH HHS 75N93019C00076NIAID NIH HHS K24 AI104831NIAID NIH HHS R01 AI118257NIAID NIH HHS R21 AI129167NIAID NIH HHS U19 AI135964NIGMS NIH HHS T32 GM008061NIGMS NIH HHS T32 GM008152NIGMS NIH HHS T32 GM144295
Abstract
Variation in the genome of
Indexed as
Genome, BacterialMachine LearningVirulenceAlgorithmsAnimalsBacteremiaFemaleGenomicsMiceMice, Inbred BALB CPhenotypeProof of Concept StudyPseudomonas aeruginosaPseudomonas Infectionsgenome analysismachine learningmodelingpredictionPseudomonas aeruginosavirulence
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.